Episodios

  • Sex and Gender Differences in Aging

    Sex and Gender Differences in Aging

    · seX & whY
    Show Notes for Episode Twenty-Six of seX & whY: Sex and Gender Differences in Aging

    Host: Jeannette Wolfe
    Guest: Sara Haag

    Dr Haag is a researcher in molecular epidemiology who studies human biological aging at the Karolinska Institute in Stockholm.

    Background - Dr Haag has a PhD in functional genomics and Post Doc in genetic and molecular epidemiology. She studies telomeres and molecular association with telomere length, she also has experience in molecular biology and computer science.

    Definitions and discussion points from podcast

    Geroscience - a new field of biomedical science that looks at how the molecular, genetic, and cellular mechanisms associated with the aging process itself may interact and even trigger many diseases associated with aging. This research provides a different angle for potential intervention to enhance health and longevity. Life Span - time between birth and death. Heath Span - time within life span of good health. Frailty Index and Clinical Frailty Scale are tools that evaluate a patient’s overall physical conditioning and their vulnerability to certain adverse outcomes including falls, increased care requirements, hospital admission, and mortality. Epigenetics - the study of how DNA expression can be modified by behavior or environmental factors (versus alteration in the actual DNA itself). One way I think of this is to imagine a huge library full of books, and that each book represents a gene coded from our DNA- epigenetics help determine which books get pulled off the shelfs and get read or pushed back deeper into the shelfs. This process is different than buying new books for the library (which would be equivalent to changing the DNA itself.) Aging Scales - as different elements of the body age differently, there is not a gold standard to measure aging. Dr Haag recently published a study that evaluated a bunch of these different scales and determined that the “ideal” scale will vary dependent upon what you are studying- such as overall function or the biological aging of a specific organ (i.e. heart or liver).

    Two major theories of aging:

    Senescence theory of aging - the belief that with age, cellular systems due to repeat exposure to intracellular and extracellular stressors, eventually start to malfunction and breakdown. Things start slowly falling apart due to wear and tear. Programmed theory of aging - Aging is an innate active process which is highly regulated by an internal time clock.

    As the field of Geroscience and epigenetics evolves, the “truth” around aging is likely to be a combo of both theories.

    Sex Differences

    Hormones

    Estrogen

    Dr Haag talked about research involving telomere length (telomeres are the cap of the chromosome and they help protect the chromosomes from damage.) Typically, telomeres shorten with repeated division in somatic cells and when they shrink to a certain length the cell is more vulnerable to error and damage. Females have longer telomere length at birth compared to males and there is evidence that women with longer exposure to estrogen have longer telomeres.

    Testosterone

    Here is the Korean Eunuch study mentioned in the podcast. The researchers examined a genealogical record of 385 eunuchs and compared their life span to several other groups of men who lived during the same time periods including a bunch of kings. They found that the average life span of a eunuch was 70 which was 15-19 years longer than the comparison groups. One theory behind this difference in longevity is “the disposable soma theory”. This postulates that in males there is competition between two different intrinsic systems - somatic aging and reproduction- and that as both systems require significant energy to maintain, when energy is diverted to one system the other suffers.

    Sex Chromosomes

    In females each cell has two X chromosomes. In female cells, one of the X chromosomes is typically inactivated so that some cells have genes expressed that are inherited by their father, while others express genes inherited from their mother. Complicating this further is that several genes do not fully inactivate that second X chromosomes so that females may have an “extra” expression of some genes. A concrete example of this is the gene Toll like receptor 7 which codes for proteins that helps the immune system recognize the early invasion of certain types of viruses. As this gene doesn’t undergo X inactivation, it may give females an extra boost in warding off certain types of viral infections.

    With aging there can be “skewing” of the X chromosome in that females may have a disproportionate percentage of cells that express the X chromosomes of a single parent.

    As male cells age, some may actually lose their Y chromosome. This news release suggests that his may happen relatively frequently as their work implied that 40% of all 70-year-olds had cellular evidence of it. The loss of Y chromosome can be associated with Alzheimer’s and heart disease in males.

    Take home points:

    1) The field of aging is absolutely exploding. Someday it may be possible to actively manipulate epigenetic signaling to slow or even reverse aging processes.

    2) Different biological processes in our bodies age at different rates. Plus, if you follow a group of people over time, as they get older there will be greater and greater differences within that group in their markers of aging.

    3) In aging research, there has historically been two different camps- the senescence camp, and the programmed theory one. In the senescence camp is the belief that as we age, things just start breaking down due to natural wear and tear. This contrasts with the programmed theory camp which believes that aging is a pre-designed active process that is triggered with age. The “truth” likely is a combination of both theories with epigenetics being the bridge.

    4) Sex differences in aging include the mortality-morbidity paradox in that although females tend to have poorer health and greater fragility risk, males still tend to die sooner.

    5) Sex differences with aging may include changes in the X chromosome with increased skewing and even the loss of the expression of the Y chromosome, both of which can be associated with an increase of health-related issues.

    Thanks for listening. May you be well (and curious). Jeannette.
  • Global Health and Pandemic Responsiveness Through a Sex and Gender Lens Part 2

    Global Health and Pandemic Responsiveness Through a Sex and Gender Lens Part 2

    · seX & whY

    Show Notes for Episode Twenty-Five of seX & whY, Part 2: Global Health and Pandemic Responsiveness Through a Sex and Gender Lens

    Host: Jeannette Wolfe
    Guests: McKinzie Gales and Emelie Yonally Phillips

    McKinzie Gales – Global Health Fellow at the CDC and co-lead for Phase I of the multi-agency SAGER IOA project aimed at facilitating better collection, analysis, and use of sex-disaggregated data and gendered data for outbreak response. Emelie Yonally Phillips – Global Health consultant (Epicentre/MSF) and core member of the Integrated Outbreak Analytics initiative

    Phase 1 of the sex and gender equity in research (SAGER) for Integrated Outbreak Analytics (IOA) study involved A systematic literature review to better understand what is already known about the influence of sex and gender in outbreaks and to investigate if sex-disaggregated data and gendered data is being collected, analyzed, and used. Five different databases were searched and articles meeting the inclusion criteria were included. All included articles were published in English between 2012-2022, included the key terms “sex,” “gender,” or “pregnancy,” and discussed infectious disease outbreaks (e.g., cholera, dengue, Ebola, zika, hepatitis E, Malaria, influenza, yellow fever) in a low- and middle-income countries. Notably, they intentionally excluded articles focused on covid and tuberculous as sex and gender research is being extensively conducted on these diseases.

    Of the 15,000+ articles in their original search, only 71 articles examined potential sex and/or gender related factors associated with outbreaks in low- and middle-income countries.

    Although currently there is very limited data on the impact that sex and/or gender play in outbreaks and pandemics, what is known, underscores the complexity of these relationships. Studying specific outbreaks in specific contexts is important because who is most likely to get infected and how rapidly an infection is spread is influenced by several intersecting factors. These include the infectious agent, sex specific immunological factors and local socio-cultural practices and norms.

    McKinzie highlighted that when there is a lack of gender and sex sensitive responses in outbreaks, evidence suggests that women, girls, and those with female anatomy are disproportionately negatively affected. For example, women are at greater risk for gender- based violence during a lock down and those with female anatomy are more directly impacted by the diversion of health care resources from clinics that offer reproductive health and pregnancy related services.

    We went through an example as to how the SAGER IOA model might work in a theoretical outbreak. In establishing a functioning multi-disciplinary team, Emelie emphasized the importance of working within local systems to build long term relationships, community trust and capacity. She underscored how critical it was to understand the values and priorities of the individuals most impacted by the outbreak and to ensure they had a voice in decision-making. She also discussed the importance of effective and transparent community health messaging- particularly if new data suggests a change from current practice. A recent example of this was the confusion experienced by many pregnant women surrounding the safety of Ebola vaccination.

    Emelie also spotlighted the opportunity to better understand how gender nonconforming and sexual minorities experience outbreaks as there is currently an absence of data on these groups. Finally, she emphasized that the failure of considering sex and gender specific needs in an outbreak can have tremendous downstream effects. Specifically, generational poverty, educational and professional inequities, gross domestic product, global trade, and security can all be impacted.

    One of the other interesting areas we touched upon was how personal protective equipment (PPE) and other medical related equipment was initially designed for the anatomy and physiology of a male body and may not always work for a female one. Below are a few articles on this point.

    Respiratory Personal Protective Equipment for Healthcare Workers. This study reported findings on adequate mask fitting in one hospital system’s fit test data for FF3 masks. Their data set suggested that 18% of women had an inadequate FF3 mask fit compared to 10% of men.

    Unions say coronavirus crisis has brought ‘into sharp focus’ the problem of women being expected to wear PPE designed for men.

    Here is a very interesting article that further explores whether medical equipment should be adjusted to better fit the anatomical variations of different users. The article - Does surgeon sex and anthropometry matter for tool usability in traditional laparoscopic surgery? makes a strong argument that most of the advances in laparoscopic surgical equipment have previously focused on accommodating different patient related factors and that their remains an opportunity to modify products to better align with anatomical characteristics of different users. In turn, this may help enhance performance, outcome, and injury prevention of the users - AKA in this case the surgeons.

    Thanks for listening and be well.

  • ¿Faltan episodios?

    Pulsa aquí para actualizar resultados

  • Global Health and Pandemic Responsiveness Through a Sex and Gender Lens Part 1

    Global Health and Pandemic Responsiveness Through a Sex and Gender Lens Part 1

    · seX & whY

    Show Notes for Episode Twenty-Five of seX & whY: Global Health and Pandemic Responsiveness Through a Sex and Gender Lens

    Host: Jeannette Wolfe
    Guests:

    McKinzie Gales – Fellow at the CDC and co-lead for Phase I of the multi-agency SAGER IOA project aimed at facilities' better collection, analysis, and use of sex-disaggregated data and gendered data for outbreak response. Emelie Yonally Phillips – Global Health consultant and core member of the Integrated Outbreak Analytics initiative

    Definitions

    IOA - Integrated Outbreak Analytics
    SAGER - Sex and Gender Equity in Research

    The Integrated Outbreak Analytics (IOA) initiative is a collaborative partnership between UNICEF, WHO, US-CDC, ITM, Epicentre, IFRC, under the umbrella of GOARN.

    The IOA concept started in earnest in 2018 during the Ebola outbreak in the Democratic Republic of Congo after it became clear that more real time, comprehensive on the ground data was needed to best manage outbreaks in an efficient and effective manner. The larger-picture concept is that the IOA model sets up a system for increased interagency data sharing and a process for data collection that produced more comprehensive information about:

    How infections spread How individuals access health systems and how patterns might evolve over time How local sociocultural norms, behaviors and expectations, impact an outbreak response and community recovery

    The IOA - Creates a more holistic response to outbreaks along the entire pipeline from prevention to treatment. It creates a model that puts lots of partners at the table including major players like Unicef, WHO, CDC, Doctors Without Borders in addition to local governmental agencies and boots on the ground health care providers.

    Examples of data that may be integrated to provide a clearer story of what is happening in an outbreak include:

    Surveillance data Health information systems data Programs data Community data Timeline event data Climate, weather and ecosystems data Local economy data

    Goal is to apply a multi-disciplinary approach to outbreak analyses to provide a more holistic and timely understanding of outbreak dynamics and provide local Ministries of Health and response actors with rapid evidence to make decisions during an outbreak.

    A key component of IOA is understanding the dynamics of both sex and gender within outbreaks and outbreak response for more adapted and appropriate responses. Therefore, IOA systematically works to collect, analyse and use data disaggregated by sex and inclusive of gender criteria across all phases of response:

    Prevention Detection Management/Treatment Response

    Four phase project

    Phase 1:

    Systematic literature review - how are sex and gender being considered in outbreak response

    Phase 2:

    Participatory engagement in real time projects that are using an IOA and identifying what is already known about site specific sex and gender differences in tools/programs. Developing survey of response actors looking at their current understanding about sex and gender and how they are or are not collecting needed information and/or analyzing and using it to guide interventions. Create workshops and small groups to address challenges identified in survey and key informant interviews, identify capacities and brainstorm on how to overcome recognized barriers. Co-create practical recommendations and strategies to more systematically integrate sex and gender into the outbreak analysis process.

    Phase 3:

    Collate Phase 2 responses from several different outbreaks to develop a larger SAGER IOA model that can then be flexibly applied to future outbreaks.

    Phase 4:

    Pilot testing in different outbreaks Evaluating responses and further modification

    Great resources

    Half the Sky: Turning Oppression into Opportunity for Women Worldwide by Sheryl WuDunn and Nicholas Kristof More information about the SAGER Guidelines Link to previous podcast with Dr Shirin Heidari who was one of the fundamental drivers of developing the SAGER Guidelines.
  • Sex and Gender Differences in Conflict - Part 2

    Sex and Gender Differences in Conflict - Part 2

    · seX & whY

    Show Notes for Episode Twenty-Four of seX & whY: Sex and Gender Differences in Conflict, Part 2

    Host: Jeannette Wolfe
    Guest: Joyce Benenson, lecturer of evolutionary biology at Harvard and author of the book Warriors and Worriers

    In this podcast we continue our discussion about women interacting with each other at the workplace and how women often manage hierarchy differently than men. We got into a spirited discussion about a question posted on a female physician’s list serve querying whether women physicians want to be addressed as “Doctor” by other staff members. (My own preference was “yes” in front of patients, and “no” once we were outside of exam rooms.) Benenson believes that when women are interacting with women who are not family, they tend to act incredibly egalitarian. This can be challenging for women in hierarchical positions and lead to a downplay of their power. This intentional buffering may not only use up a lot of cognitive energy, but it can also be a potential disadvantage in professional situations that require a clear chain of command to optimize team performance. This can put women on a professional tightrope that can be hard to balance. Ways to address this include acknowledging that this challenge is real, committing to direct communication and focusing on shared outcome goals of the entire team. Personally, I have also found it extremely helpful to humanize the other person and remind myself that most people don’t go to work with malicious intent to try and screw up another person’s day.

    Next, we talked about likeability, and Benenson shared a fascinating economics paper called: I (Don’t) Like You! But Who Cares? Gender Differences in Same Sex and Mixed Sex Teams. This paper included a series of studies in which pairs participated in games that involved economic transactions and “likeability”. In pairs where men worked with other men, “liking” their partner was not intricately related to maximizing their profits. This was not the case in teams that involved at least one woman. In these pairs, likeability increased the chance of profits and dis-likability decreased overall profits. This suggests that when interreacting with each other, men may have a greater ability to compartmentalize their professional interactions from their personal opinions.

    Next, we talked about the “tend and befriend” theory developed by Dr Shelly Taylor. This theory suggests that when stressed, that females may benefit less from a fight or flight response and more from coming together to pool resources and share childcare. Benenson’s impression is that there is little scientific evidence that this theory holds true. She believes, contrary to the popular stereotype, that males are actually far more likely to be the communal sex and are much more likely to form intense group bonds.

    At the end, I briefly reviewed some of the findings of a recent paper Dr Benenson published called: Self Protection as an Adaptive Female Strategy which supports the “Staying Alive Theory”. From an evolutionary perspective, behaviors that are more likely to be found in groups of males than females, such as direct competition, physical aggression, resource accumulation and risk taking, have evolved because they provide a benefit to males in optimizing their mating opportunities and reproductive fitness. The question becomes, is there a parallel evolutionary driver for females. The Staying Alive Theory is one proposal. This theory originally developed by Campbell in 1999, suggests that compared to males, females are more likely to be innately wired to avoid conflict and be more physiologically responsive to threats that can jeopardize their health. By doing so, this helps females optimize their chance of their own fitness and the survival of their own offspring. In their paper, Benenson and her group surveyed several different areas of science to look for support of the Staying Alive Theory and here are some of their findings.

    In humans and other mammals, females seem to consistently outlive males, this is particularly true in species in which grandmothers are more heavily involved in caring for infants. There is a health-survival paradox, however, in that although females may have greater longevity, they are also more likely to report the presence of daily symptoms and chronic illness and have higher prescription drug use. In the world of sex and gender-based medicine this phenomenon is nicely summed up with the phrase men die, women suffer. There are sex differences in most types of cancers, in fact, except for thyroid and breast cancers, males have higher incidences of most other cancers and usually have a worse prognosis after diagnosis. Compared to female, males are also more susceptible to most infectious diseases. An as an aside, when we talk about Covid, it is estimated that globally for every 10 females who have died from it, 13-15 males have. During times of global threats, females are also more likely to follow through with public health messaging such as mask wearing and hand washing Females, compared to males, have a heightened sense of pain, which may enhance self-protective behavior to avoid situations in which injury may occur such as physical arguments In general, females are more likely to have more frequent night-time awakenings, suggesting they may be more vigilant to potential night threats than male counterparts. This tendency to break up their sleep however may be compensated by higher quality length and depth of different parts of the sleep cycle. As a group, women appear to be more concerned about environmental issues and according to a recent study involving more than 32 nations and 45,000 participants, women felt a greater urgency to protect the environment and were more likely to support policies that financially invested in it. When looking at how people communicate, females were more likely to use techniques associated with politeness including smiling and tentative language that included buffering and apologizing. Although the area of nonverbal recognition shows some mixed results, overall, it appears that females are better at identifying nonverbal expressions especially those related to fear, sadness and anger.

    This is a great paper and worth a full read if you are interested in this material.

    Thanks for listening to Sex and Why!

  • Sex and Gender Differences in Conflict - Part 1

    Sex and Gender Differences in Conflict - Part 1

    · seX & whY

    Show Notes for Episode Twenty-Four of seX & whY: Sex and Gender Differences in Conflict, Part 1

    Host: Jeannette Wolfe
    Guest: Joyce Benenson, lecturer of evolutionary biology at Harvard and author of the book Warriors and Worriers

    Here is a link to Dr Benenson’s book Warriors and Worriers.

    This book dives deep into the evolutionary roots of human behavior and Dr Benenson makes a very clear and well referenced case that human males and females have evolved from slightly different playbooks. The root of this difference is sexual selection in that adaptions and behaviors that optimize the chance that a male’s DNA gets into the next generation are slightly different than a female’s, specifically Benenson asserts that a female’s strategy relies more heavily on keeping herself and her children physically safe and healthy. Innate differences may then by amplified or attenuated by sociocultural norms and experiences that shape an individual’s “expected behavior."

    Some bullet points from her work

    Evolutionary biology focuses heavily on the behavior of non-human primates Much of the behavior observed in other primates can also be seen in humans When studying human behavior, it can be very hard to untangle behavior rooted in biological sex versus sociocultural influence. This is because the two are tightly interwoven and even if you intentionally raise your child to be “gender blind”, the child will still be exposed to significant gendered expectations by peers and broader societal exposures. Many of the behaviors seen in adult humans can be visibly observed by watching pre-school children. Boys and girls (for this podcast we are concentrating on the book ends of the gender spectrum: boys/men and girls/women) typically exhibit different behaviors as children. Boys are more likely to participate in rough and tumble play and are more comfortable with hierarchy and rotating allegiances in groups. Girls prefer playing in smaller groups of two and three. Many girls find in quite difficult to participate in larger groups consisting only of females, as they feel increased pressure to effectively navigate the different relationships within that group. Chimpanzees, like human males, are two of the few species that engage in “warfare” or systematic behavior to attack other groups of their own species. Groups of male chimpanzees that are good at this behavior enhance the survival of the rest of their group by expanding food and territory. Benenson believes some of this warfare behavior has genetically evolved into humans and that it is further enhanced by learned sociocultural practices. Benenson has extensively studied conflict and how males and females have different evolutionary consequences to direct aggression. She strongly believes that females are wired to avoid direct conflict to optimize their physical ability to bear and rear children to their own reproductive age.

    This is Dr Benenson’s study that looked at how much time two players spent interacting with each other after the conclusion of a competitive sports match. It showed that men typically engaged longer with their opponent than did women. She theorizes this behavior suggests that men tend to be more agile in realigning these relationships because the relationship may be needed for a future allegiance (i.e. in war or hunting.)

    Please tune in next month for Part 2 of this series.
  • Issues Surrounding Men’s Health - Part 2

    Issues Surrounding Men’s Health - Part 2

    · seX & whY

    Show Notes for Episode Twenty-Three of seX & whY: Issues Surrounding Men’s Health, Part 2

    Host: Jeannette Wolfe
    Guests:
    Peter Baker – Director of Global Action on Men’s Health
    Twitter: @pbmenshealth @globalmenhealth

    Dominick Shattuck has a PhD in psychology and does Global Health Work at Johns Hopkins Bloomberg School of Public Health

    https://www.linkedin.com/in/dshattuck/

    Main topics discussed:

    Challenges and barriers associated with optimizing men’s mental health and the role of men in reproductive health-related issues.

    Men’s mental health is important not just for men but for the health of communities. Maladaptive coping mechanisms such as substance use disorder and aggression can impact gender-based violence, sexual and reproductive health, and the well-being of children. Part of tackling gender-based violence needs to include helping men better manage anger and stress.

    Barriers to mental health for men

    From a young age, many boys are taught to suck things up and not show signs of physical or emotional weakness. They also may struggle to find words to adequately articulate their emotional state or to appropriately label the challenges which they are experiencing. This may be further confounded by social media in which most posted photos portray men as carefree and perfect which can leave the viewer feeling inadequate and questioning their masculinity. Today many men may also have decreased contact with their extended families and thus may miss out on many of the informal connections and conversations that have historically helped men cope with common life challenges.

    We then discussed some unanticipated and potentially detrimental consequences of “gender blind” policies. For example, due to concern of exclusivity, there has been a decrease in what historically were Men’s Only spaces. These closures can be costly for men who already have a fragile support system and who relied on these organizations to help them connect and bond with other men. Dominick then talked about the importance of code switching for men (using different communication styles with different audiences) and that in the ideal world we would create opportunities for men to become more proficient in the different roles they play (i.e. father, husband, employee etc) by exposing them to spaces with different audiences like men’s only, couples, and mixed gender gatherings.

    Peter also brought up that mental health related depressive symptoms may just look differently in men. Consequently, many men and their health care professionals, may not be aware that some of the symptoms that men are describing (such as increased alcohol consumption) are often flags for depression.

    Next, we discussed what roles men can play when it comes to areas surrounding reproductive health and reproductive justice. Dominick talked about some of the work he has done for a task force funded by the US Aid for use in low and middle-income countries to help better define these roles. He described a three-pronged framework- men as potential clients (i.e. work around condom use and vasectomies), as supportive partners to women, and as advocates for change. Messaging this framework so that men understand that these issues are not just relevant for women is critical. Peter also believes that this is an area in which Men’s Advocacy Groups can likely help so that women are not shouldering this load alone.

    One of the take home moments for me was a story Dominick shared about the first time in his entire life that he had a talk with a medical doctor about family planning was when he was in the urologist’s office getting his vasectomy. I embarrassingly admitted that as an ER doctor when I am speaking to a male patient about condom use it is usually in the context of me treating them for an STD and my focus is primarily on preventing future infections not future babies. Made me realize that even in my speciality there are some opportunities.

    Here are links to some of the information we discussed.

    Mental Health Survey

    Here is the article about Dominick’s work and his commentary related to the Covid Trends and Impact Survey. This is an online survey on Facebook that has surveyed millions of people across the world. Dominick’s study focused on over 12 million participants in 115 countries from May 2021 to Sept 2021 and found that 37% of men reported feelings or depression and 34% of anxiety with younger men reporting higher levels than older ones. These numbers were similar to the percentages of anxiety and depression reported by women. Men also reported that getting more resources on how to maintain their mental health was one of their top priorities surrounding the pandemic. Their findings were somewhat atypical because outside of Covid, women are typically much more likely to report symptoms of anxiety and depression and men are much more likely to under-report their symptoms, suggesting that COVID has caused significant suffering for men. Interestingly, it also hints that COVID may have helped some men to be more open to the concept of counseling and mental health related services.

    Post-partum Depression in Men

    Interestingly, when we think about post-natal depression, we tend to think it is something that only happens to newborn mothers, but Peter suggests that it is also relatively common in men. As this shocked me, I dug around a little.

    Per this JAMA article about 10% of men suffer from postpartum depression but the rate can be as high as 1 in 4, 3-6 months after birth.

    Factors that might contribute to postpartum depression in men

    Decreasing testosterone Lack of sleep (and sex) No longer being partner’s primary focus Stress of feeling they must provide for partner and child Feeling guilty that they should be happier with their new child Postpartum depression in their female partner

    Again, interestingly, fathers are usually not asked questions about their own coping

    Here is a summary of the paper we discussed that helped a hyper-masculine profession - offshore oil workers - change their culture surrounding safety.

    Take home points

    We need more data that analyzes sex and gender differences in medical conditions. One area that Peter feels is particularly understudied is the economic cost associated with ignoring key aspects of men’s health. Having better numbers around these costs could help elevate the issue amongst researchers and policy makers When we talk about mental health, as there are both sex-based biological factors and gender based sociocultural expectations that contribute to it, there are different, often significantly different, challenges associated with the optimization of mental health for men compared to women. As a result, depression in men often goes unrecognized and undertreated and this can contribute to the increased rates of isolation and suicide in men. Tackling men’s mental health related issues requires a multi-prong approach including education and the intentional creation of different types of sociocultural accepted spaces where men can seek support and learn coping skills. When considering men’s role in reproductive health, Dominick shared a three-prong framework. Men as clients, men as supportive partners to women and men as advocates for change. The use of effective messaging to engage men in these issues is critical especially as to this point reproductive health has been considered a “women’s issue” in which men have by and large been excluded. Finally, there is a need to bridge many Men’s and Women’s Health Advocacy Groups more effectively. As the health of a community is dependent upon the health of all its members, these groups share a lot of common goals and there is significantly opportunity for greater coordination.

    Thanks for listening to seX & whY,
    Jeannette

  • Issues Surrounding Men’s Health - Part 1

    Issues Surrounding Men’s Health - Part 1

    · seX & whY

    Show Notes for Episode Twenty-Three of seX & whY: Issues Surrounding Men’s Health, Part 1

    Host: Jeannette Wolfe
    Guests:
    Peter Baker – Director of Global Action on Men’s Health
    Twitter: @pbmenshealth @globalmenhealth

    Dominick Shattuck has a PhD in psychology and does Global Health Work at Johns Hopkins Bloomberg School of Public Health

    https://www.linkedin.com/in/dshattuck/

    Here is a list of Peter Baker’s publications including Men’s Health Policy: it is Time for Action.

    Here is a list of Dominick Shattuck’s publications

    Take home points

    Somewhat ironically even though most major health related organizations are dominated by men in senior positions, men’s health is often left out of the agenda. Some of this may be due to a zero-sum game mentality in that it is commonly viewed that the only way to fund men’s health is to take away funding from women’s health. This isn’t necessarily true, and it is important to remember that healthy families and communities are rooted in healthy parents regardless of their biological sex or gender. Men have about a 5-year shorter live span than women and are increased risk for diabetes, early hypertension, substance you disorder and suicide. Peter noted that men’s health has not had the grassroots advocacy that many women’s health initiatives have had. He attributes this to a belief held by many men that they are strong and independent and as they value the perception of being able to tough things out, advocating for increased health access to medical and mental health resources may be at odds with their desired self-image. We also discussed the different challenges that men compared to women may face when trying to increase their health literacy or navigate access to appropriate services. This is particularly evident in early adulthood. During this young adult period, females often have an increased awareness of their body and health related issues due to fertility associated concerns, while for many men health related issues often fall off their radar and if they are discussed, the information may be poorly vetted and inaccurate. We talked about this two and even three decades long health care desert where men can find themselves and in where they have little to no interaction with traditional health systems. We then spoke a great deal about health messaging and the importance of getting the right message to the right men via the right platform. As Dominick noted, currently a great deal of health messaging is geared towards the category of men that Dominick refers to as “the low-lying fruit” in that they may already have access to a pcp and have good baseline health literacy. He feels strongly that there is a great opportunity to increase engagement with a broader variety of men by respecting their different values and tailoring messages to specific subsets using different types of platforms like integrating important public health messages into radio and TV series.

    Please join us next month for a continuation of our conversation in which we will focus on issues surround men’s mental health and the roles that men may play in the shifting landscape of reproductive justice.

  • Sex, Drugs, and Rats

    Sex, Drugs, and Rats

    · seX & whY

    Show Notes for Episode Twenty-Two of seX & whY: Sex, Drugs, and Rats

    Host: Jeannette Wolfe
    Guest: Dr Irv Zucker, Faculty at UC Berkley since 1966. Interests include behavioral endocrinology, chronobiology, and sex differences in pharmacology

    General discussion

    Many times, the worlds of basic science and human clinical trials do not overlap to the degree that they should. Greater coordination between the two silos, especially as it comes to the examination of sex differences, would likely produce more robust, higher quality science that would benefit a greater number of patients.

    In a good deal of drug research, the amount of basic science research done on a particular drug prior to market release is often quite limited. As significant drug side effects may only be identified after the drug’s release, using established animal models that match up well to conditions similarly experienced in humans, may help identify potential problems earlier in the drug development pipeline. Dr Zucker believes that this is particularly important when trying to evaluate for specific behavioral side effects in the offspring of pregnant or lactating females using certain drugs (see his paper here). As these side effects in humans may take 10-15 years to be identified, leveraging the shorter natural life cycles of lab animals could help flag potentially deleterious effects years before they might otherwise be identified by traditional post-release surveillance data. There are two big governmental National Institute of Health policies that shifted research to become more inclusive of sex/gender.

    1993 NIH Revitalization Act. To get NIH funding for human clinical trials researchers needed to include or explain why they were not including, both men and women in clinical trials

    2016 Sex as a Biological Variable. Applied above rules to basic science lab work. Irv and his team’s work were instrumental in triggering this policy change.

    Sampling of Dr Zucker's Research

    This paper surveyed prominent journals from 10 different areas of basic science research and highlighted that the consideration of the existence of sex differences was rarely considered by pre-clinical researchers. Most studies included only male animals with less than 25% including both sexes. Some concerning numbers in specific fields were totally lop-sided. For example, in neuroscience there was a 5:1 male to female animal ratio

    Follow up research reexamined these numbers after the 2016 guideline change and showed:

    Almost 50% included both sexes in research but
.. 1/3 of researchers didn’t give breakdown of how many males and females they included in study. (Meaning researchers could have included 10, 50 or 70 percent of animals from one sex.) Some fields like pharmacology still were underrepresented (less than 30% of research included both sexes) When both sexes were included only about 40% broke down their outcome data by sex

    Here is the paper we discussed that busted the myths surrounding female animal variability and numbers needed to study: Female mice liberated for inclusion in neuroscience and biomedical research.

    This is a meta-analysis of almost 300 different articles examining behavioral, physiological, and molecular trials in female and male mice without regards to estrous cycle and found that female animals were no more variable and at times even less variable than males. This was doubly surprising because the dogma had been that male hormonal variability was insignificant. Interesting both males and female animals became much more variable when housed with other animals.

    Next, we talked about pharmacokinetics: Sex differences in pharmacokinetics predict adverse drug reactions in women. They evaluated 86 drugs in which they could find published information about pharmacokinetics broken down by biological sex (for example, if the drug was absorbed, distributed, metabolized and excreted similarly or differently in male and female bodies) and then compared these findings with a data base that evaluated for adverse side effects.

    Of 86 drugs with available information (of note in the vast majority of currently used medications this information is NOT readily available) they found 76 of drugs had greater levels in women with an 88% correlation of higher levels being associated with adverse drug reactions in women

    Bottom line - when giving a drug to a female start at the lowest dose possible and review other scripts they are taking to avoid potential drug/drug cross-reaction.

    Also here is the amazing story of Dr Frances Kelsey who stood tall against the tremendous pressure by the manufacturers of thalidomide to approve the drug in the United States. Her request to not approve the drug without additional data ultimately saved the lives and physical disabilities of countless babies.

    Take home points from podcast

    Historically the vast amount of basic science research was done only on male animals thereby potentially missing important findings that may be unique to a specific sex. The inclusion of female animals in and by themselves do not produce greatly variability in basic science research results. In fact, in many cases, using male animals may produce significant variability suggesting that male hormones may not be as consistent as once believed. The bottom line is, it depends on what you are studying and there are easy to apply scientific methods that can allow you to determine if hormonal variation may be playing a part in outcome results without using excessive amounts of animals. Pharmacokinetics of how a drug is absorbed, distributed, metabolized and excreted are often influenced by biological sex, yet very few drugs that are currently on the market have adequate and accessible data on pharmacokinetics broken down by biological sex. Drugs that have greater concentrations in a female body correlate to the chance of an increased likelihood of an adverse reaction. If you prescribe medications, it is a good rule of thumb to start at the lowest possible dose in a female and to ensure you review their med list to avoid predictably adverse cross reactions. The ethics around studying drugs in pregnant and lactating females are challenging especially as many of these drugs may have side effects that will not be apparent for decades. One way to help fill this gap is to run parallel basic science studies that examine long term behavior changes in animals after drug exposure.

    Thanks for listening!

  • Sex and Gender Differences in Opioid Use Disorder

    Sex and Gender Differences in Opioid Use Disorder

    · seX & whY

    Show Notes for Episode Twenty-One of seX & whY: Opioid Use Disorder

    Host: Jeannette Wolfe
    Guests:
    Dr Alyson McGregor, author of Sex Matters: How Male-Centric Medicine Endangers Women's Health and What We Can Do About It
    Dr Lauren Walter

    Here is link to American Psychiatric Association DSM 5 diagnosis for opioid use disorder from the CDC. Essentially the disorder is defined by continued craving and use of opioids despite significant social and professional consequences caused by its use.

    This podcast is on sex and gender differences in opioid use disorder. Although sex (s) and gender (g) are rooted in different etiologies - biological sex via innate chromosomal and hormonal characteristics while gender is heavily influenced by sociocultural factors, they are often heavily interconnected. Experiences influence gene expression through epigenetics and if a man is exposed to different experiences than a woman, they can have different epigentic responses. Further complicating things, however, is that if a male and a female have the same experience, they can have a different pattern of gene expression because the process of epigenetics itself is influenced by innate sex. Currently, if researchers are even looking for s/g differences in their data, they are usually doing so at a very basic level like patient reported demographics, this makes further exploration as to whether discovered differences are rooted in innate physiology or cultural influences difficult. Essentially, appreciating the current limitations of research, we will use the term “men” and “women” in this blog.

    To highlight how recent the trend in research has been to even consider the potential influence of sex and gender as relevant factors in pain. A 2007 study that looked at over 10 years of research published in the journal Pain, found that almost 80% of their studies included only male animals and less than 4% looked at sex differences.

    Stats

    CDC- Opioid deaths accounted for > 70% of all deaths from drug overdoses (totally overdose deaths 70,630)

    2019 Kaiser Family Foundation data

    Opioid Overdose Deaths

    2019 total deaths

    Men

    Women

    49,860

    34,635

    15,225

    2020 data https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm - total overdoses > 93,000 estimates that 69,710 from opioids.

    For comparison 2020 mortality numbers for car crashes were 38,680

    Sex and Gender Differences

    Women

    more rapid acceleration from first use to addiction and treatment entry Greater medical and psychiatric co-morbidities Younger Greater barriers to accessing treatment including managing childcare, transportation, and drug use stigma Increased risk of engagement of high risk sexual activity (risk further increased for sexual minorities) Maybe more responsive to buprenorphine

    Men

    Older History of more substantial use increased history of legal/criminal activity

    Overall, in women compared to men, the prescription opioid abuse is decreasing more slowly while heroin use in increasing more quickly.

    “From 1999 to 2010, overdose deaths increased 265% among men and 400% among women (CDC, 2018)”

    Once in treatment have similar outcomes

    Multidimensional approach - medical and psychosocial needs - these may be different for men and women

    Sex and Gender gaps in the literature

    Many studies done before the explosion of the opioid epidemic Limited data on people who are not in residential treatments or clinical trials Many studies focus on methadone which has different treatment setting and clinical management

    Socioeconomic differences between typical methadone vs buprenorphine users

    Buprenorphine users more likely to be white, healthier, younger and from higher socio-economic class

    Increasing comprehensive services such as: housing, childcare and social support can help both men and women but what type of services they need and utilization of services may be sex/gender specific

    Women tend to engage more in comprehensive services (may reflect greater psychosocial burden) and offering sessions with childcare or mother’s support group may help with follow through and improve outcomes Stigma against women who are pregnant and/or mothers may also impair ability to access treatments

    May increase women’s participation by adding women support group and childcare services

    Take Home Points

    There are sex and gender physiological and sociocultural factors that come into play in substance use disorder

    Statistically men are more likely to have an issue with opioid use disorder however those numbers are narrowing Physiologically- females appear to be at greater risk for telescoping- in that they appear to be at greater risk for rapid acceleration in substance use an physiological dependence, they also may be more prone to side effects surrounding withdrawal such as nausea How people spiral into abuse may also be heavily influenced by sex/gender related factors as men often get hooked due to increased use in social situations, while women often are using alone and self-medicating for depression and anxiety. How they pay for their drug use is also gender influenced with men often resorting to stealing or criminal activity and women to sex trafficking Over the last few years there has been a cultural shift as to how to best manage patients with substance use disorder with a greater focus on harm reduction versus complete abstinence with the understanding supported by data, that harm reduction can dramatically decrease the morbidity and mortality associated with substance use disorder and improve the health of local communities. Due to the opioid epidemic, there has been multiple initiatives to better identify and treat patients with substance use disorder including state wide prescription monitoring program, systemwide policies and electronic medical record prompted physician guideline for prescribing, and ED administered counseling, medical assisted therapies and harm reduction kits

    Finally, we talked about Alyson’s important work with the Sex and Gender Summit which is geared towards integrating sex and gender-based principles across health care curricula to better educate future providers.

    Here are two great resources to learn more on how to do searches to include sex and gender:

    www.sexandgenderhealth.org
    www.amwa-doc.org/sghc/

  • Interview With Dr Shirin Heidari Part 2: Gendro - Advancing Sex and Gender Equity in Science Research

    Interview With Dr Shirin Heidari Part 2: Gendro - Advancing Sex and Gender Equity in Science Research

    · seX & whY

    Show Notes for Episode Twenty of seX & whY: Interview With Dr Shirin Heidari Part 2: Gendro - Advancing Sex and Gender Equity in Science Research

    Host: Jeannette Wolfe
    Guest: Shirin Heidari PhD, virologist and experimental oncologist, founding President of Gendro.

    Part 2 of Interview with Dr Shirin Heidari

    This podcast focuses on Dr Heidari’s work on systematically integrating the variables of sex and gender into different access points along the research pipeline. She helped start an organization called Gendro which is dedicated to this mission.

    The three major gatekeeping posts that Gendro and other organizations are targeting are:

    1) Funding

    Require the inclusion of both male and female animals or justify an exclusion

    2) Ethical Review Boards

    These boards review research protocols prior to study enrollment to ensure that the researchers have designed their study to meet national and organization protocols designed to protect participants from being involved with unethical or dangerous practices. Traditionally these boards have been an overlooked area to target.

    3) Journals

    As many medical publishing house multiple journals, if they modify their standardized template to include query about sex and/or gender analyses, they have the power to rapidly change the expectations of authors and peer reviewers surrounding the inclusion of these factors.

    In addition, we talked about the SAGER guidelines

    SAGER guidelines a.k.a. Sex and Gender Equity in Research. These guidelines were put together by an international team of researchers in 2015 and geared towards giving researchers, journal editors, peer- reviewers and publishers better tools to include and evaluate the variables of sex and gender in scholarly work. Although the guidelines have increased the awareness and inclusion of these variables, and many journals have now adopted them, there continues to be a significant opportunity for more widespread use. A recent editorial highlights some of the barriers to utilization and possible concerns.

    Here is a synopsis of some of the remaining barriers.

    Perceived Barrier

    Solution

    Mandated inclusion will significantly increase overall research costs from enrollment to additional statistical analysis

    Underscore that several countries have already been successful in tying initial funding with inclusion criteria which suggests that some of resistance is likely due to ingrained culture rather than significant financial barriers. Highlight that some countries have developed new supplemental funding to enhance adoption. *

    Journal editors may have significant time and resource limitations that prohibit their ability to formally introduce or monitor SAGER guidelines.

    Emphasize that optimizing science requires constant evolution and that as editors they are already well skilled in helping their journal comply with other required updates. Including SAGER guidelines can enhance the quality of research their journal publishes and in turn enhance its reputation.

    In additional, engaging publishers to invest in better science by making system wide changes in both editorial expectations and technical support (see below) could rapidly accelerate adoption.

    Peer reviewers may feel ill-equipped to evaluate for the proper inclusion of sex and gender in a review due to knowledge gaps in core principles surrounding sex and gender

    Provide access to available online trainingmodules such as those offered by the Canadian Institutes of Health Research.

    Enhance diversity training as who is at the table influences policy and priorities.

    Technical challenges. Many publishers use the same templates across multiple journals which may limit an individual journal’s ability to change their own format.

    Engage editors to encourage publishers to update digital templated formatting to reflect SAGER principles. The inclusion of a requested digital check off page in submission requirements confirming guideline compliance, could serve both as a reminder cue to the author and a screening tool to journal staff to ensure that it is completed prior to forwarding material to reviewer. This would help minimize any additional time the reviewer would need to spend to ensure SAGER compliance.

    * As an aside, identifying important sex-based differences in pre-clinical studies may ultimately be quite cost effective as they may lead to the design of more successful and cost-effective clinical trials

    We also discovered the opportunities to include the variables of sex and gender in COVID vaccine research and here are two important papers that Dr Heidari just published in this area.

    A Systemic Review of the Sex and Gender Reporting in Covid-19 Clinical Trials.

    75 initial published trials- 24% presented data broken down by sex and only 13% included in their discussion any discussion about potential sex differences.

    Time for Action: towards an intersectional gender approach to COVID-19 vaccine development and deployment that leaves no one behind.

    Take home points from article

    sex and age-based differences in immunology may influence vaccine dosing/side effects sex based differences may influence gendered associated acceptance and uptake of vaccines (for example if it is known that women get more side effects with a vaccine it may influence another women’s readiness to get vaccinated.) sociocultural associated factors can influence vaccine acceptance and uptake it is critical to have meaningful inclusion of gender diverse voices in high level research and policy decisions.

    This now becomes very relevant as we now know that there are significant sex differences in side effects in the vaccines including increased risk of myocarditis for males in Pfizer and Moderna (According to a recent Australian study done by their equivalent of the FDA, the Therapeutic Goods Administration (TGA) numbers may occur up to 1 in 10,000 in younger men. Of note, they suggest that chance of getting myocarditis from Covid is likely 8-10x this risk.)

    Conversely women are more likely to get increased risk of clotting with the J and J vaccine.

    Thanks for joining us!
  • Interview With Dr Shirin Heidari Part 1: Sex and Gender Variables in Science Research

    Interview With Dr Shirin Heidari Part 1: Sex and Gender Variables in Science Research

    · seX & whY

    Show Notes for Episode Twenty of seX & whY: Interview With Dr Shirin Heidari Part 1: Sex and Gender Variables in Science Research

    Host: Jeannette Wolfe
    Guest: Shirin Heidari PhD, virologist and experimental oncologist, founding President of Gendro.

    Part 1 of this podcast spotlights the opportunity to do better science by paying more attention to the variables of sex and gender.

    Many times, we simply assume that when we study a medical question in a clinical trial that who is in the trial, adequately represents the population of folks who are affected by the condition being studied. When it comes to the consideration of gender, often this is not true. Dr Heidari and her team did a systemic review that evaluated study participant’s gender in HIV research trials, although more than 50% of people who have HIV are women, only 19% of participants in anti-retroviral trials were women.

    In 1993 the NIH passed the Revitalization Act in which NIH funded studies would be required to study both men and women. A parallel mandate for basic science research passed over 20 years later in 2015. In some ways this is incredibly nonsensical because most of medical research starts out in the basic science lab. If you don’t include animals of both sexes, in adequate numbers, from the beginning, you could be later blindsided in an expensive clinical trial by a physiological sex-based differences that could have been picked up earlier.

    Even though there has been progress over the past 30 years, Dr Heidari repeatedly makes the case that just because there are guidelines to include males and females in trials, this does not mean that these guidelines are adhered to or adequately enforced. In addition, there is often a large divide between including men and women in a study and doing an appropriate analysis to see what happens to those men and women. Essentially including both men and women isn’t all that helpful unless you breakdown your results also by gender. Importantly, the very best studies go even a step further - they include a calculation in the original study design to determine how many men and how many women would need to be included in a study so that if a difference is found that the researchers can be more confident that the difference represents a real finding and not a statistical blip.

    Another important point discussed, is the chance for skewing of study results if researchers don’t consider the gender breakdown of who drops out of a trial. Although it is not uncommon for studies to have a small number of participants drop out (and this can happen for a bunch of different reasons ranging from side effects to an inconvenient study location) it is uncommon for them to report the gender breakdown of the dropouts. If significantly more women, or men, drop out of a trial this could be a red flag that something else might be going on and hint to potential problems with the study’s conclusions.

    Our conversation then veered to discussing pharmacokinetics and pharmacodynamics. Pharmacokinetics tells us about how the body influences a drug - specifically how a drug gets absorbed, distributed, and metabolized. Pharmacodynamics, on the other hand, tells us how the drug influences the body. An example I like to use is to compare giving someone a medication to hiring a secret agent. In both cases, there is a break in, a job and an exit. Traditionally it was believed that, outside of extreme differences in body weight, that drugs worked similarly- break in/job/exit - in male and female bodies if the drug did not target a reproductive organ. We now know this default “no sex difference” assumption is not scientifically valid as there are many drugs which work differently in male and female bodies and that these differences have clinical relevancy.

    An example of this is a study we discussed on marijuana pharmacokinetics with women requiring far less amount of marijuana to experience the same cognitive effects. In the discussion section of this paper it suggests that previous studies may have under-appreciated this sex-based difference because they often had higher dropout rates in women which likely skewed their final study results. And here is the link to some of the material we discussed surrounding the knowledge gap on pregnancy and pot-smoking and how this gap has caused some pregnant women to reach out to non-traditional resources to get information.

    Other studies we mentioned

    Here is a study that suggests that the gender of the researcher or lab tech may subtly influence research results.

    Here is a study that suggests that male and female animals both have similar amounts of hormonal variation.

    In part two we will discuss possible solutions.
  • About Vaccine Research

    About Vaccine Research

    · seX & whY

    Show Notes for Episode Nineteen of seX & whY: About Vaccine Research

    Host: Jeannette Wolfe
    Guests:

    Christine Dahlke, Biologist and vaccine researcher at University Medical Center Hamburg-Eppendor and The German Center for Infection Research Marylyn M Addo, Physician, Professor, Infectious disease specialist and vaccine researcher from University Medical Center Hamburg-Eppendor and The German Center for Infection Research

    Link to their paper: Sex Differences in Immunity: Implications for the Development of Novel Vaccines Against Emerging Pathogens

    Take-home points

    Vaccine development has evolved over the years from having each vaccine be independently developed “one drug for one bug” to “plug and play” platform technology in which a vector that predictably and effectively triggers the immune system is attached to a new pathogen’s antigen (or mRNA or DNA that codes for that antigen), allowing for a much more accelerated development of new vaccines because researchers are not starting from scratch every time. Researchers often test antibody levels to determine vaccine efficacy but, immunization changes other aspects of the immune system such as t cell response and some innate immunity too. These changes may be more difficult to test but may also be important for long term protection even if antibody levels fall. Traditionally, drug companies have not been all that excited about developing vaccines due to the lack of a profit margin compared to a drug someone needs to take every day. The Coalition for Epidemic Preparedness Innovation (CEPI) helped jump start vaccine development in 2017 (apparently this was sparked by the realization that Ebola could have become a global pandemic and that we needed more tools to develop rapid turn- around vaccines.) Sex differences - due to sex hormones and chromosomes - influence how a body’s innate and adaptative immune system works. Women generally having an advantage in fighting off infection by having a more robust innate and adaptative immune system. This may come at a cost of increased risk for autoimmune disease and in Covid, women are also much more likely to have long haul Covid symptoms. Age can act as an additional confounder with males having more impaired antibody response and increased innate inflammatory responses with age Most immune cells have sex steroid receptors on them Many genes that influence the immune system are housed on the X chromosome and some of them like Toll-like receptor 7 - aka the Paul Revere of the early immune response, may not undergo X-inactivation leading to it’s over expression in females and possibly giving them an advantage in decreasing their viral load compared to males after similar exposures.

    Other references:

    Paper referred in podcast about Dr Klein: Bishof E, Wolfe J, Klein S - Clinical trials for COVID-19 should include sex as a variable.

    Podcast from last summer with my interview with Evelyn Bishof and Sabra Klein about Sex Differences in Immunology and Drug Therapy

    Herpes vaccine trial showing efficacy in females and not in males.

    Here are some videos on the immune system:

    Dr Iwasaki Made Easy New York Times article nicely explaining how different vaccines work
  • Mike Gisondi Announces Stanford's New, Open Access Course,

    Mike Gisondi Announces Stanford's New, Open Access Course, "Teaching LGBTQ+ Health"

    · seX & whY

    Show Notes for Episode Eighteen of seX & whY: Mike Gisondi Announces Stanford's New, Open Access Course, "Teaching LGBTQ+ Health"

    Host: Jeannette Wolfe
    Guest: Dr Mike Gisondi, Vice Chair of Education at the Department of Emergency Medicine at Stanford University

    How prepared are you to teach the next generation of medical learners about issues surrounding care issues of LGBTQ patients?

    What if you could have a free (yes, free) and totally cool resource to increase your knowledge and confidence about this material.

    Drumroll



    Introducing- with perfect timing to align with LGBTQ health awareness week- an online CME course called:

    Teaching LGTBQ+ Health: a faculty development course for health professions educators.

    Access through Stanford Educational Technology

    Not a health care provider? No problem! You can access this information too! Did we say that it is free, free, free!

    Trailer: http://bit.ly/TeachLGBTQHealth

    Course Site: https://mededucation.stanford.edu/courses/teaching-lgbtq-health

    Stanford’s Teaching LGBTQ+ Health course: Learners across the health professions demand improved LGBTQ+ health content and additional training opportunities in their schools’ curricula. However, most clinician educators received little, if any, training in LGBTQ+ health when they were students. This free, online, CME course addresses the gap between expected faculty teaching competency and a lack of previous faculty training.

    The course is open access to educators across the health professions, as well as other providers, staff, trainees, and patients. It includes both LGBTQ+ health content and recommendations for teaching this material to trainees in any discipline or clinical department. Educators may freely download portions of the course for use in their daily clinical teaching or their school’s curriculum.

    Authors:
    Michael A. Gisondi, MD
    Shana Zucker, MD/MPH/MS (cand.)
    Timothy Keyes, MD/PhD (cand.)
    Deila Bumgardner, MA

  • Impact of Gendered Masculinity in Health Engagement and Decision-making

    Impact of Gendered Masculinity in Health Engagement and Decision-making

    · seX & whY

    Show Notes for Episode Seventeen of seX & whY: Impact of Gendered Masculinity in Health Engagement and Decision-making

    Host: Jeannette Wolfe

    Guests:
    Dr Fahad Saeed, Nephrologist and Palliative Care Specialist from the University of Rochester

    Dr Lauren J. Parker, PhD, Dual PhD in Gerontology and Health Promotion, scientist at the Johns Hopkins Bloomberg School of Public Health

    The topic today discussed how masculinity and race can impact access to health and health related decisions.

    Take home points

    Overall, men have a shorter life expectancy than women and this is likely influenced by both biologically and sociocultural based factors associated with an individual’s gender identity Race based stressors amplify these sociocultural mortality differences Men are less likely to access preventative health care services and some of this is likely related to biological sex differences and behavioral patterns that begin in early adulthood as females are more likely to interact with health systems due to pregnancy and child related issues. Sociocultural “masculinity norms” may discourage health engagement due to an individual’s desire to be perceived as tough and independent. Ways to better engage men with their health (with an emphasis on men of color)

    Increase public messaging to normalize the need for men’s preventative health

    Increase diversity amongst medical providers

    Reach men where they are like sporting events, barber shops and churches

    Acknowledge and appreciate the unique roles and challenges that many men face

    Target and adjust messaging to engage men at different life points

    Men can get caught in a warrior-like mentality which may impact their end-of-life choices. In cancer patients this may make them less receptive to palliative care due to a concern that it may suggest that they are “giving up”.

    Palliative care is a specialty that helps patients, and their families cope with a life shortening illness and to optimize their quality of life. Patients in palliative care can still receive aggressive disease modifying therapy like chemotherapy with the except of patients receiving “hospice care”. Hospice care, although still under the palliative care umbrella, has slightly different rules. Under hospice, it is recognized that a patient is likely in their last 6 months of life and that they would no longer benefit from aggressive treatments, all care is redirected to optimize comfort.

    Dr Saeed’s tips surrounding palliative care engagement in men with advanced cancer

    Normalize messaging such that palliative care is considered a natural part of cancer treatment Appreciate impact of non-verbal language- be authentic in conversation Recognize that most conversations have a logical and emotional component and appreciate that both need to be addressed Take time to know the patient’s story, this humanizes the interaction and increases empathy Remember goal is to figure out their preferences and then honor them Sometimes shifting focus from fighting terminal cancer to fighting for comfort and to ease families suffering can make patients more amenable to palliative care services

    Links

    - Dr Lauren Parker’s paper that examines ways to more effectively engage men in their health.
    - List of her other publications-
    TEDX Rochester talk by Dr Saeed
    - Links to Dr Saeed’s publications
    - His specific research that we discussed
    - 2012 paper that Dr Saeed referenced by Susan Wong

  • Interview with Dr Saralyn Mark

    Interview with Dr Saralyn Mark

    · seX & whY

    Show Notes for Episode Sixteen of seX & whY: Interview with Dr Saralyn Mark

    Host: Jeannette Wolfe

    Dr Mark has had an incredibly interesting and eclectic career. She is trained in Endocrine, Geriatrics and Women’s Health and has worked for and/or consulted with:

    The Office of Women’s Health in Department of Health and Human Services, NASA and 4 different Whitehouse Administrations

    She has also written the book Stellar Medicine: A Journey through the Universe of Women’s Health

    In addition, she has founded two different companies

    Solamed Solutions a boutique consulting firm that advances scientific and strategic direction for public and non-public sectors The non-profit iGIANT (Impact of Gender and Sex on Innovations and Novel Technologies)

    Our discussion features some of the highlights of Dr Mark’s career as well as surveys a bunch of uncommonly recognized, yet important sex and gender based differences in medicine, technology and industry. We talk about sex and gender based differences in military equipment, PPE, laparoscopic tools, automobile safety and Covid-19.

    This is the link to Jane Henry’s See Her Work site that Dr Mark references.
  • Sex Differences in Immunology and Drug Therapy

    Sex Differences in Immunology and Drug Therapy

    · seX & whY

    Show Notes for Episode Fifteen of seX & whY: Sex Differences in Immunology and Drug Therapy

    Host: Jeannette Wolfe

    Guests:

    Evelyne Bischof MD, Associate Professor of Medicine at Shanghai University of Medicine and Health Sciences and internist at University Hospital of Basel Switzerland

    Sabra Klein, PhD, Professor of Molecular Microbiology and Immunology at Johns Hopkins Bloomberg School of Public Health

    This podcast focused on sex differences in immunology and pharmacology and its relevance to the Covid-19 pandemic.

    Key points

    Males are more likely to be admitted to the ICU and die from COVID-19 compared to females Males and females have differences in both innate and adaptive immunity (which likely are a combo of chromosomal, hormonal and epigentic differences) One difference in Innate immunity (the initial non-specific reaction to a foreign pathogen) is Toll-like receptor 7 (TLR7) This is a major player in the initial physiological response to a foreign pathogen and the gene for it is on the X chromosome. X-lined genes (like Ace-2 which is the receptor which SARS-Cov-2 initially binds to in the body) are interesting because they immediately bring up two considerations. First, if someone has a specific variant of that gene, it could change their susceptibility to certain pathogens. Males, as they have an XY pair of sex chromosomes, only have one X chromosome and thus could be more adversely impacted than females (XX) who have a second copy of the gene (which may or may not express the same variant) from their other X chromosome. The second consideration is that in the cells of most females, one of the X chromosomes is automatically turned off (X inactivation). It appears however, that some X-linked immune cells- like TLR7- don’t do this, leading to the possibility of increased expression of the gene like getting an “extra dose”. In adaptive immunity (which involved B and T cells), females generally have a greater immunological response to most pathogens. As such, females generally exhibit a more robust immune response to natural infections and vaccinations. The flip side, however, is compared to men, women are also at greater risk for autoimmune diseases and are more likely to get local and systemic reactions after a vaccination. When testing the effectiveness and side effects of SARS-CoV-2 vaccines it would be ideal to consider the variables of biological sex and age. In an influenza study, when women were given a Âœ dose of the flu vaccine, they mounted a similar immune response to males who got full dose. If the same held true for developing SARS-Cov2 vaccinations, it could potentially increase the amount of vaccine available (though it is unclear if this is even being considered in early vaccine trials). Aging can also impair the immune response and older adults may require higher doses of booster doses of some vaccines to optimize their immune response The use of Artificial Intelligence in drug development may revolutionize the pharmaceutical research industry by allowing more predictive drug modeling leading to more successful drug development. This could also be used to better identify potentially important biological sex- based pharmacodynamic and pharmacokinetic differences earlier in drug development.

    Two unexpected findings associated with COVID-19

    Males appear to be more vulnerable to cytokine storm (mechanism still not entirely clear may be differences in ACE-2 receptors, or chromosomal/hormonal differences in innate/adaptive immune system) Elderly sick males who survived COVID-19 appear to have significant protective antibody production against SARS-Cov2

    References:

    Bischof E, Wolfe J, Klein S: Clinical trials for Covid-19 should include Sex as a Variable. JCI 2020

    Engler R, Nelson M, Klote M, et al. Half- vs Full-Dose Trivalent Inactivated Influenza Vaccine (2004-2005) Age, Dose, and Sex Effects on Immune Responses, JAMA Internal Medicine 2008

    Gender and COVID-19 Working Group website

    Global Health 50/50 global deaths disaggregated by sex

    Klein S, Pekosz A, Park H. et al. Sex, age and hospitalization drive antibody responses in a Covid-19 convalescent plasma donor population. JCI 2020

    Roberts M, Genway S How Artificial Intelligence is transforming drug design. DDW

    Souyris M, Cenac C, Azar P, et al. TLR7 Escapes X Chromosome Inactivation in Immune Cells. Autoimmune Disease 2018

    Takehiro T, Ellingson M, Wong P et al. Sex Differences in Immune Responses that underlie COVID-19 disease outcomes. Nature 2020

    Zucker I, Prendergast B. Sex differences in pharmacokinetics predict adverse drug reactions in women. Biology of Sex Differences 2020

    Special thanks to Doug Deems for help with editing

  • COVID-19 Through a Gender-Based Lens Part 2

    COVID-19 Through a Gender-Based Lens Part 2

    · seX & whY

    Show Notes for Episode Fourteen of seX & whY: COVID-19 through a Gender Based Lens Part 2

    Host: Jeannette WolfeGuests: Dr Gary Barker CEO of Promundo- an organization that promotes healthy masculinity and gender equality

    Dr Stephen Burrell Assistant Professor in the Dept of Sociology at Durham University - whose area of focus in on engaging men and boys in the prevention of violence against women.

    Here are some of the take-home points of our discussion.

    The need to clearly label preliminary studies as “preliminary” to avoid early adoption of inadequately proven therapies The importance of both including both males and females in research drug trials and in analyzing results by biological sex. (For example, from toxicology research it is known that females are at greater risk for drug-induced QTc prolongation - which can trigger a dangerous arrhythmia- than men, yet this consideration was not taken into the design and analysis of almost all the hydroxychloroquine studies even though we know that QTc prolongation is one of this drug’s most well-known side effects. The need to go beyond biological sex to look at social and environmental determinants that help identify “which men” or “which women” (or “which nonbinary person”) is at greatest risks so that we can better direct interventions. This approach often quickly spotlights longstanding heath inequity issues. If the goal is to improve health outcomes to consider subtly shifting the approach away from how can men better engage with health care systems towards how can health care systems better engage with men is quite important. Dr Barker shared an excellent example of a project he was involved with in Brazil in which men were approached during their partners prenatal clinic visits to make their own health related appointments. This pandemic has been associated with some significant collateral health related damage including: people being afraid to seek out medical care for true emergencies; huge shortages of reproductive health services; increasing prevalence of domestic violence; and mental health related issues triggered by loneliness and isolation.


    Here is the link to the Pew Study that Dr Barker mentioned.

    Here is the link for the Harvard GenderSci

    Here are some links for the challenges India is having with obstetrical care including this NY Times article

    Amanda Nguyen's Rise UP 19 program that allows domestic violence victims to be helped by restaurant owners.

    Special thanks to Doug Deems who helped me edit this podcast.

  • COVID-19 Through a Gender-Based Lens Part 1

    COVID-19 Through a Gender-Based Lens Part 1

    · seX & whY

    Show Notes for Episode Fourteen of seX & whY: COVID-19 through a Gender Based Lens Part 1

    This is a discussion on how gender-associated norms impact disease process.

    Host: Jeannette Wolfe
    Guests: Dr Gary Barker CEO of Promundo- an organization that promotes healthy masculinity and gender equality

    Dr Stephen Burrell Assistant Professor in the Dept of Sociology at Durham University- who’s area of focus in on engaging men and boys in the prevention of violence against women.

    Today’s podcast features the first part of our discussion which focuses on how “gender” roles and norms impact general health and the COVID-19 pandemic. Both of our guests are experts on how societal perceptions and stereotypes surrounding “masculinity” influence the health and well-being of both men and women. Through Promundo, Dr Barker has done significant amounts of work in Brazil where toxic masculinity has been associated with the early deaths of millions of young men and Dr Burrell recently wrote the article: Coronavirus reveals just how deep macho stereotypes run through society.

    Our discussion focuses on:

    The intentionality required to engage diverse groups of people to actually talk about how gender and masculinity associated issues significantly impact health outcomes. Research from Promundo which suggests that of the about overall 5 year mortality difference between men and women, that about 20% of that gap is due to genetics and about 50% is associated with the following three factors: diet smoking substance abuse The recognition that more men than women are dying of Covid-19 and that we need to go beyond binomial data to look at “which” men and “which” women are at highest risk for death which leads us to the intersection of biological sex and other sociocultural influences. How the words different countries use to describe the pandemic often appear to reflect that country’s approach in how they are addressing it. The importance of intentionally creating neuro and cultural diversity amongst teams tasked to solve complicated problems. Special thanks to Doug Deems who helped edit this podcast.
  • LGTBQI Health-related Issues Part 3

    LGTBQI Health-related Issues Part 3

    · seX & whY

    Show Notes for Episode Thirteen of seX & whY: LGTBQI Health-related Issues Part 3

    How best to support students and colleagues in the LGBTQ community

    This is a very special podcast and I want to deeply thank Shana Zucker, Ellie Ragone and Mike Gisondi for sharing their very personal experiences.

    Host: Jeannette Wolfe
    Guests:

    Shana Zucker, MS

    Shana is a rising 4th year medical student at Tulane in the MD/PhD program When she was a first-year medical student at Tulane she helped to create The Queericulum, an educational program geared at helping medical students become more culturally competent surrounding LGTBQ health related issues and patient interactions Since its creation, it has now become a mandatory course for all first-year Tulane medical students and she is currently working to expand the program to other medical schools In addition, she and Mike are creating (with another MD/PhD student at Stanford) an online educational program to help medical educators teach medical students about LGTBQ health Here is Shana’s talk at Feminem’s Fix conference in NYC

    Ellie Ragone DO

    Is a first-year emergency medical resident at UMMS-Baystate Ellie is a transwoman and has graciously shared her personal experiences about transitioning as a medical student One of her largest concerns about transitioning was being able to successfully identify a primary care provider who was both competent and comfortable with LGTBQ patients and their health-related needs

    Michael Gisondi

    Vice chair of education at the Dept of EM at Stanford Mike shares how his identity formation was actually quite different at different points of his own life He reflects on the generational differences of LGBTQ physicians

    Tips offered by the group

    If you have a trans colleague and you misgender them, besides apologizing in real-time, consider sending them an email or text later on to let them know you have reflected upon the mistake and appreciate the challenges they are routinely facing and that you want to support them. When you are looking at a program or job, be authentic and find the program who accepts you for who you are versus trying to be the image of the person you think the program wants. Let medical students and residents lead. They often are much more on point about what does and doesn’t work than most senior educators

    Accountability buddy article

    https://www.aliem.com/peer-accountability-strategy-maintaining-commitment/

    Special thanks to Doug Deems who helped me edit this podcast

  • LGTBQI Health-related Issues Part 2

    LGTBQI Health-related Issues Part 2

    · seX & whY

    Show Notes for Episode Thirteen of seX & whY: LGTBQI Health-related Issues Part 2

    How to take better care of transgender patients when they seek medical care

    Host: Jeannette Wolfe
    Guests:

    Dr Elizabeth Samuels Assistant Professor of Emergency Medicine Warren Alpert School of Medicine at Brown University Dr Michelle Forcier Professor of Pediatrics at Warren Alpert School of Medicine at Brown University and Director of Gender and Sexual Health Services

    Quotes used are from Dr Samuel and her team’s paper: “Sometimes You Feel Like the Freak Show": A Qualitative Assessment of Emergency Care Experiences Among Transgender and Gender-Nonconforming Patients Ann Emerg Med 2018

    Here are 10 take-home points

    Delivering Intentional habits to care for our transgender patients actually helps us deliver better care to our cisgender patients too. Appreciate that many trans and gender non-conforming patients are incredibly reluctant to seek out medical care due to previous discriminatory treatment, Don’t assume a trans patient is out to the other people in the room and offer to speak with them privately Ask their name, if different than expected ask them if they have a different legal name, then confirm how they would like to be addressed and what pronouns they use. Respectfully update other team members about this information so that the patient doesn’t need to unnecessarily repeat themselves. Importantly how we model this message to our staff can set the tone for how these patients will be treated, so take this responsibility seriously. When asking about past medical history, surgical histories and current medication make sure that you are clear as to why you are asking and how it relates to their current medical problem. In trans patients that present with abdominal pain, don’t assume because they physically look like their asserted sex that they lack organs from their biological one such as ovaries or a prostate. Remember to ask. When admitting a trans patient, if a private room is unavailable they should be roomed with patients of their asserted gender. If not already doing so, encourage your hospital to use software that allows an individual’s sexual orientation and gender identity to be included in a separate field of their medical record If you are a medical educator, look for ways to include an issue
  • Mostrar más